In episode 1 of our yet-to-win award podcast, we talk to Dr. Sandeep Kumar, Distinguished Research Fellow in Biotherapeutics at Boehringer Ingelheim about how he uses computers to help develop and deliver biopharmaceuticals and his thoughts on the increasing importance of computational methods in drug discovery.  It gets controversial at times, so, you know, just a warning on that. See more:

Computational Antibody Discovery: State of the Art: https://www.antibodysociety.org/computational-antibody-discovery-state-of-the-art/ Takeaways:

• Dr. Sandeep Kumar is driven by a desire to help patients.
• Computational methods can revolutionize antibody discovery.
• In silico antibody discovery can overcome traditional limitations.
• AI can generate vast libraries of antibodies efficiently.
• Medicine-like profiles can improve drug developability.
• Collaboration between tech and biotech is essential.
• Digital transformation is crucial for the pharmaceutical industry.
• Data digitization is necessary for effective informatics systems.
• Computational predictions need to be validated in the lab.
• The future of drug discovery lies in integrating computation with experimentation.

What's this all about, you ask? In today's inaugural episode of our sure-to-be award-winning podcast, we'll cover the who, what, and why we decided to create this podcast.  As well as preview industry topics we'll be covering in future episodes.

This is not your average science podcast - Welcome to Under the Surface.

For more information on Chemical Computing Group, head to: https://www.chemcomp.com/.

The podcast aims to share:

• Insights from the field of drug discovery.
• Computational chemistry is evolving with new technologies and AI.
• There is a mix of hope and skepticism in the field.
• Understanding the sociology behind software use is important.
• Big pharma and small biotech have different approaches to innovation.
• The history of CCG provides valuable context for current practices.
• Structural information plays a crucial role in drug discovery.
• The podcast will feature discussions with industry experts.
• New technologies are often applied in innovative ways by smaller firms.
• The future of drug discovery is promising with advancements in AI.